A controlled clinical trial of tiaspirone in schizophrenia.
Jain A K, Kelwala S, Moore N, +1 more·International clinical psychopharmacology
The antipsychotic efficacy of tiaspirone, a new atypical antipsychotic agent, was compared to standard neuroleptics, in a single-blind cross-over study. Nine actively psychotic schizophrenic patients entered the study and 6 completed it. Significant overall improvement, on BPRS and CGI ratings, occurred by week 4, on b…